To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the most definitive test. A surgeon will remove all or part of an affected lymph ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...

Has come back (relapsed) within a year of treatment or does not go away (refractory) after your first treatment Has relapsed or is refractory and you cannot receive a hematopoietic stem cell ...

In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de ...

The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...

—Tycel Phillips, MD, hematologist/oncologist at City of Hope Duarte Cancer Center in California walks through what to consider when treating these patients. (2:03 ...

For some people, treating follicular lymphoma involves active surveillance until severe symptoms develop. For others, chemoimmunotherapy, radiation therapy, or targeted treatments may be necessary.

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, ...

Lymphoma is an aggressive cancer that starts in the lymphatic system and occurs more frequently in individuals living with HIV. HIV-related lymphoma begins in the lymphatic system, a vital part of the ...